ArticleScientific reports2026
The astrocyte marker ALDH1L1 also identifies a stromal cell population in the lymph node.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CTMAP: an adversarial cross-modal learning framework for accurate and robust cell-type annotation in single-cell resolution spatial transcriptomics.Briefings in bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
ALDH1L1 is widely used as a marker of astrocytes in the central nervous system (CNS), but its expression and potential roles in the periphery, particularly in lymphoid organs, remain poorly understood. Here, we found that ALDH1L1+ cells comprise approximately 5–9% of the lymph node (LN). To better understand their identity, we investigated whether these cells share characteristics with glial, immune, endothelial or stromal cell populations under homeostatic conditions. Using ALDH1L1/TdTomato reporter mice, immunofluorescence, and flow cytometry, we found that TdTomato+ cells in LNs do not coexpress canonical CNS (GFAP, ACSA-2) or peripheral glial (Sox10) markers. Similarly, using multiple approaches we found minimal overlap with T cells (CD3, TCRβ), B cells and dendritic cells (B220), myeloid cells (CD11b, Iba1), or antigen presenting cells (MHCII). To explore potential stromal associations, we assessed coexpression of TdTomato with endothelial (CD31, LYVE1) and reticular (ER-TR7) markers and found insubstantial overlap. In contrast, TdTomato+ cells showed significant colocalization with podoplanin (PDPN), a marker of fibroblastic reticular cells (FRCs). Interestingly, while many TdTomato+ cells were PDPN+, relatively few PDPN+ cells expressed TdTomato. Notably, ALDH1L1+PDPN+ cells were enriched in the paracortex and medulla but absent from the B cell follicles and subcapsular sinus. These findings suggest that while ALDH1L1 remains a reliable marker of astrocytes in the CNS, it may also delineate a distinct subset of FRCs in the LN, opening new avenues for exploring stromal cell diversity and function in lymphoid tissues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.